Literature DB >> 33242410

Circulating miRNA Spaceflight Signature Reveals Targets for Countermeasure Development.

Sherina Malkani1, Christopher R Chin2, Egle Cekanaviciute3, Marie Mortreux4, Hazeem Okinula5, Marcel Tarbier6, Ann-Sofie Schreurs7, Yasaman Shirazi-Fard3, Candice G T Tahimic7, Deyra N Rodriguez8, Brittany S Sexton8, Daniel Butler2, Akanksha Verma2, Daniela Bezdan9, Ceyda Durmaz2, Matthew MacKay2, Ari Melnick10, Cem Meydan2, Sheng Li11, Francine Garrett-Bakelman12, Bastian Fromm6, Ebrahim Afshinnekoo13, Brad W Langhorst8, Eileen T Dimalanta8, Margareth Cheng-Campbell14, Elizabeth Blaber15, Jonathan C Schisler16, Charles Vanderburg17, Marc R Friedländer6, J Tyson McDonald18, Sylvain V Costes3, Seward Rutkove4, Peter Grabham5, Christopher E Mason19, Afshin Beheshti20.   

Abstract

We have identified and validated a spaceflight-associated microRNA (miRNA) signature that is shared by rodents and humans in response to simulated, short-duration and long-duration spaceflight. Previous studies have identified miRNAs that regulate rodent responses to spaceflight in low-Earth orbit, and we have confirmed the expression of these proposed spaceflight-associated miRNAs in rodents reacting to simulated spaceflight conditions. Moreover, astronaut samples from the NASA Twins Study confirmed these expression signatures in miRNA sequencing, single-cell RNA sequencing (scRNA-seq), and single-cell assay for transposase accessible chromatin (scATAC-seq) data. Additionally, a subset of these miRNAs (miR-125, miR-16, and let-7a) was found to regulate vascular damage caused by simulated deep space radiation. To demonstrate the physiological relevance of key spaceflight-associated miRNAs, we utilized antagomirs to inhibit their expression and successfully rescue simulated deep-space-radiation-mediated damage in human 3D vascular constructs.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NASA; Twins Study; antagomirs; miRNA-seq; microRNA; microgravity; scATAC-seq; scRNA-seq; space radiation; spaceflight

Year:  2020        PMID: 33242410     DOI: 10.1016/j.celrep.2020.108448

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  5 in total

1.  Space flight associated changes in astronauts' plasma-derived small extracellular vesicle microRNA: Biomarker identification.

Authors:  David Goukassian; Arsen Arakelyan; Agnieszka Brojakowska; Malik Bisserier; Siras Hakobyan; Lahouaria Hadri; Amit Kumar Rai; Angela Evans; Aimy Sebastian; May Truongcao; Carolina Gonzalez; Anamika Bajpai; Zhongjian Cheng; Praveen Kumar Dubey; Sankar Addya; Paul Mills; Kenneth Walsh; Raj Kishore; Matt Coleman; Venkata Naga Srikanth Garikipati
Journal:  Clin Transl Med       Date:  2022-06

2.  Knowledge Network Embedding of Transcriptomic Data from Spaceflown Mice Uncovers Signs and Symptoms Associated with Terrestrial Diseases.

Authors:  Charlotte A Nelson; Ana Uriarte Acuna; Amber M Paul; Ryan T Scott; Atul J Butte; Egle Cekanaviciute; Sergio E Baranzini; Sylvain V Costes
Journal:  Life (Basel)       Date:  2021-01-12

3.  A dry immersion model of microgravity modulates platelet phenotype, miRNA signature, and circulating plasma protein biomarker profile.

Authors:  Laura Twomey; Nastassia Navasiolava; Adrien Robin; Marie-Pierre Bareille; Guillemette Gauquelin-Koch; Arnaud Beck; Françoise Larcher; Gerardene Meade-Murphy; Sinead Sheridan; Patricia B Maguire; Michael Harrison; Bernard Degryse; Niall M Moyna; Claude Gharib; Marc-Antoine Custaud; Ronan P Murphy
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

Review 4.  Space omics research in Europe: Contributions, geographical distribution and ESA member state funding schemes.

Authors:  Colleen S Deane; Willian A da Silveira; Raúl Herranz
Journal:  iScience       Date:  2022-02-15

5.  The Impact of Spaceflight and Microgravity on the Human Islet-1+ Cardiovascular Progenitor Cell Transcriptome.

Authors:  Victor Camberos; Jonathan Baio; Ana Mandujano; Aida F Martinez; Leonard Bailey; Nahidh Hasaniya; Mary Kearns-Jonker
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.